title: Decreased selenium levels after peptide receptor radionuclide therapy (PRRT) in patients with neuroendocrine tumours: implications for the antioxidant status.
authors: Roy
authors: R
authors: Moncayo
authors: Annette
authors: A
authors: Traeger
references: J Environ Radioact. 2003;64(1):19-25
references: 12469768
references: Cell Mol Life Sci. 2009 Aug;66(15):2457-78
references: 19399585
references: J Clin Oncol. 2003 Jun 15;21(12):2335-41
references: 12805335
references: Eur J Nucl Med Mol Imaging. 2011 Apr;38(4):605-12
references: 21365250
references: Eur J Nucl Med Mol Imaging. 2005 Oct;32(10):1131-5
references: 16133381
references: J Biol Chem. 2008 Mar 14;283(11):6854-60
references: 18174160
references: BMC Endocr Disord. 2008 Jan 25;8:2
references: 18221503
references: Eur J Nucl Med Mol Imaging. 2011 Apr;38(4):623-32
references: 21170526
references: Acta Physiol Hung. 2006 Jun;93(2-3):131-6
references: 17063624
references: West Indian Med J. 2009 Jan;58(1):50-3
references: 19565998